Sort
23,748 grants matching “melanoma”
Genomics Shared Resource
$221,010Louise C Showe · Wistar Institute · P30 · FY2019 · CA
Genomics Shared Resource
$221,010Louise C Showe · Wistar Institute · P30 · FY2022 · CA
Control of Eye Melanoma Metastsis
$220,903Hans E Grossniklaus · Emory University · R01 · FY2010 · CA
Control of Eye Melanoma Metastasis
$220,903Hans E Grossniklaus · Emory University · R01 · FY2009 · CA
Control of Eye Melanoma Metastasis
$220,903Hans E Grossniklaus · Emory University · R01 · FY2008 · CA
Metabolic modulation of alkylating agent efficacy in MEK inhibitor resistant thyroid cancers.
$220,894Ioanna Papandreou · Ohio State University · R21 · FY2022 · CA
SIGNALING MECHANISMS FOR WNT PROTEINS
$220,860University Of Connecticut Sch Of Med/Dnt · R01 · FY2001 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
$220,820Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2002 · CA
Project 3: Modified RNA and LNP formulation as immunomodulatory agents for cellular immunity
$220,785Theresa M Raimondo · Brown University · P20 · FY2025 · GM
Research Project 2: Development of Synergetic EKR Combinations in PDAC
$220,593Andrea Wang-Gillam · Washington University · U54 · FY2019 · CA
Blood-based detection of BRAF DNA as a biomarker in metastatic melanoma patients
$220,545David Polsky · New York University School Of Medicine · R21 · FY2012 · CA
Regulation of Wnt Gradient Formation by Palmitoylation
$220,519Laura W. Burrus · San Francisco State University · S06 · FY2009 · GM
Role of L1-CAM in Melanoma Progression and Agiogenesis
$220,500University Of California San Diego · R01 · FY2004 · CA
Role of L1-CAM in Melanoma Progression and Agiogenesis
$220,500University Of California San Diego · R01 · FY2003 · CA
Development of Targeted Nanogels for siRNA Delivery to Tumor Vasculature
$220,500Joseph Anthoney Vetro · University Of Nebraska Medical Center · R21 · FY2007 · EB
Microbial Exposures across the Lifespan and Cancer Risk in Women
$220,500Christina A Clarke · Cancer Prevention Instit Of California · R21 · FY2010 · CA
Role of L1-CAM in Melanoma Progression and Agiogenesis
$220,500University Of California San Diego · R01 · FY2005 · CA
Indolecarbinol target proteins and anti-cancer signaling in human melanoma cells
$220,444Gary L Firestone · University Of California Berkeley · R01 · FY2015 · CA
Indolecarbinol target proteins and anti-cancer signaling in human melanoma cells
$220,444Gary L Firestone · University Of California Berkeley · R01 · FY2012 · CA
METALLOPROTEINASE INHIBITORS IN TUMOR PROGRESSION
$220,418Children'S Hospital Los Angeles · R01 · FY2000 · CA
Effect of oncolytic herpesvirus on the tumor microenvironment
$220,399Paul Rider · Lsu Health Sciences Center · P20 · FY2021 · GM
COLLAGEN STRUCTURAL MODULATION OF TUMOR BEHAVIORS
$220,387Florida Atlantic University · R01 · FY2001 · CA
Abrogation of Therapeutic Escape Pathways in BRAF Mutant Melanoma
$220,387Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2014 · CA
Efficacy of A Behavioral Intervention to Reduce Skin Cancer Risk Among Patients
$220,298Kimberly A Mallett · Pennsylvania State University, The · R21 · FY2016 · CA
Type-1 Antigen Presenting Cells in CNS Tumors - Key to Efficient Anti-Tumor T-Cel
$220,235Hideho Okada · University Of Pittsburgh At Pittsburgh · P01 · FY2011 · CA